Table 3.
Coagulation and fibrinolytic changes in the two groups of each study.
| First author and year of publication | APTT | D-Dimer | Fibrinogen | t-PA | PAI-1 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| SCH | EU | SCH | EU | SCH | EU | SCH | EU | SCH | EU | |
| B. Müller (5) | 26 ± 3 | 27 ± 3 | — | — | 2.5 ± 0.5 | 2.4 ± 0.4 | 6 ± 4 | 6 ± 4 | 56 ± 35 | 52 ± 38 |
| Z. Cantürk (8) | 29.6 ± 3.4 | 28.3 ± 1.8 | 0.52 ± 0.75 | 0.39 ± 0.27 | 329.0 ± 51.2 | 314.5 ± 27.1 | 3.60 ± 1.70 | 4.05 ± 1.76 | 19.78 ± 6.20 | 10.18 ± 3.61 |
| M.A. Ozcan (6) | — | — | — | — | — | — | 6.05 ± 2.61 | 6.27 ± 2.21 | 51.11 ± 20.97 | 46.03 ± 27.24 |
| S. Guldiken (17) | — | — | 0.29 ± 0.22 | 0.18 ± 0.11 | — | — | — | — | — | — |
| S. Gullu (10) | 26.9 ± 8.5 | 25.7 ± 7.6 | — | — | — | — | — | — | — | — |
| R. Jorde (18) | — | — | — | — | — | — | 11.1 ± 4.3 | 10.5 ± 5.1 | 15.3 ± 10.3 | 14.4 ± 13.1 |
| C. Erem (9) | 31.5 ± 3.1 | 30.0 ± 2.4 | 0.41 ± 0.3 | 0.24 ± 0.15 | 291.9 ± 50.5 | 309.6 ± 69.8 | 11.0 ± 8.5 | 8.6 ± 2.5 | 26.4 ± 10.2 | 27.1 ± 8.1 |
| Y.H. Chen (19) | — | — | 0.29 ± 0.16 | 0.15 ± 0.08 | — | — | 0.27 ± 0.16 | 0.42 ± 0.19 | 0.78 ± 0.33 | 0.40 ± 0.19 |
| S.C. Zhong (20) | 34.38 ± 6.56 | 30.41 ± 2.77 | — | — | 2.83 ± 0.60 | 2.64 ± 0.35 | — | — | — | — |
| R. Lupoli (21) | — | — | 220.3 ± 67.1 | 252.1 ± 72.4 | — | — | 5.56 ± 2.22 | 4.75 ± 1.61 | 33.6 ± 13.9 | 22.5 ± 5.74 |
| Y.X. Ren (22) | — | — | — | — | 3.93 ± 0.91 | 3.61 ± 0.89 | — | — | — | — |
| F. Gao (23) | 23.88 ± 4.46 | 26.19 ± 2.97 | 0.62 ± 0.28 | 0.73 ± 0.29 | 3.11 ± 0.69 | 2.67 ± 0.59 | 6.60 ± 2.10 | 5.43 ± 1.99 | 28.74 ± 7.35 | 25.77 ± 8.17 |
APTT, activated partial thromboplastin time; t-PA, tissue type-plasminogen activator; PAI-1, plasminogen activator inhibitor 1; —, undescribed.